Key Insights

Highlights

Treatment Research

2 treatments under study, led by Losartan

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05619653Phase 3Active Not Recruiting

Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Showing all 1 trials

Research Network

Common Treatments

  • Losartan1
  • Prednisolone1

Active Sponsors

  • Alcedis GmbH1
  • Bayer1
  • Valentina Puentmann1
  • Goethe University Frankfurt1

Top Investigators

Related Conditions

  • Left Ventricular Dysfunction1
  • Remodeling Vascular1
  • Microvascular Angina1
  • Covid19 Associated Cardiac Involvement1
  • Long Covid1

Activity Timeline